Placebo-controlled trial of cytisine for smoking cessation.
BACKGROUND: Cytisine, a partial agonist that binds with high affinity to the α(4)β(2) nicotinic acetylcholine receptor, is a low-cost treatment that may be effective in aiding smoking cessation. This study assessed the efficacy and safety of cytisine as compared with placebo. METHODS: We conducted a...
Main Authors: | West, R, Zatonski, W, Cedzynska, M, Lewandowska, D, Pazik, J, Aveyard, P, Stapleton, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
by: Aveyard, P, et al.
Published: (2009) -
Potential uses of cytisine for smoking cessation in menopausal women – literature summary
by: Francisco Rubio Rubio, et al.
Published: (2023-04-01) -
Cytisine and the failure to market and regulate for human health.
by: Aveyard, P, et al.
Published: (2013) -
Quitline in smoking cessation
by: Irena Przepiorka, et al.
Published: (2019-03-01) -
Managing smoking cessation.
by: Aveyard, P, et al.
Published: (2007)